Virax Biolabs VRAX
NASDAQ VRAX
$3.19 -0.26 (-7.39%)
As of: Aug 21, 2026 · 3:59 PM EDT

Virax Biolabs (VRAX) Current Leases (2024 - 2026)

Virax Biolabs (VRAX) posted quarterly Current Leases of $81102.0 for Q1 2026, up 53.04% year-over-year from $52993.0 in Q1 2025, and up 53.04% quarter-over-quarter from $52993.0 in Q1 2025.

Virax Biolabs (VRAX) Current Leases (2024 - 2026) Analysis & Trends

Virax Biolabs' Current Leases history runs 3 years deep, the most recent figure standing at $81102.0 for Q1 2026.

  • In Q1 2026, Current Leases rose 53.04% year-over-year to $81102.0; the TTM figure through Mar 2026 stood at $81102.0 (up 53.04% YoY), while the FY2026 annual figure was $81102.0, up 53.04% from the prior year.
  • Current Leases for Q1 2026 stood at $81102.0, up from $52993.0 in the prior quarter.
  • The five-year high for Current Leases was $81102.0 in Q1 2026, with the low at $47955.0 in Q1 2024.
  • The 3-year median for Current Leases is $52993.0 (2025), against an average of $60683.3.
  • The sharpest annual moves came in 2025 and 2026: Current Leases rose 10.51% in 2025, then jumped 53.04% in 2026.
  • Virax Biolabs' Current Leases stood at $47955.0 in 2024, then grew by 10.51% to $52993.0 in 2025, then surged by 53.04% to $81102.0 in 2026.
  • Business Quant data shows VRAX's Current Leases at $81102.0 in Q1 2026, $52993.0 in Q1 2025, and $47955.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 720.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 21.95 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 45.93 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 6.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Virax Biolabs 1.31 Mn -5.13 Mn - 81,102.00

Historic Data

Download Data
DateValue
Mar 31, 2026 81,102.00
Mar 31, 2025 52,993.00
Mar 31, 2024 47,955.00